CLINICAL_TRIALS
trial_result
· 2022-03-18
Clinical Trial Update: A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies [Phase 1]
Summary
Phase 1 study of PF-04449913 in Japanese patients with select hematologic malignancies, including acute myeloid leukemia, has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2022-03-18